back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2022-05-31 21:50 Tx date 2022-05-26 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+3,000,000 vol |
3,650,000 | |
| Filed 2022-05-31 21:48 Tx date 2022-05-26 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,150,000 | |
| Filed 2022-04-01 14:09 Tx date 2022-04-01 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,190
+17,000 vol $0.07 each |
30,500 | |
| Filed 2022-03-24 16:45 Tx date 2022-03-23 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+100,000 vol |
180,000 | |
| Filed 2022-03-24 16:44 Tx date 2022-03-23 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-100,000 vol |
10,000 | |
| Filed 2022-03-17 15:30 Tx date 2022-03-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,000,000 vol |
3,000,000 | |
| Filed 2022-03-17 15:29 Tx date 2022-03-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-1,000,000 vol |
750,000 | |
| Filed 2022-03-17 15:26 Tx date 2022-03-16 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+500,000 vol |
1,000,000 | |
| Filed 2022-03-17 15:25 Tx date 2022-03-16 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-500,000 vol |
0 | |
| Filed 2022-03-08 17:42 Tx date 2022-03-08 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+300,000 vol |
350,000 | |
| Filed 2022-02-15 19:25 Tx date 2022-02-15 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+500,000 vol |
1,750,000 | |
| Filed 2022-02-10 15:19 Tx date 2022-02-10 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+300,000 vol |
350,000 | |
| Filed 2022-02-10 15:16 Tx date 2022-02-09 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+110,000 vol |
110,000 | |
| Filed 2022-02-10 15:14 Tx date 2020-09-08 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-02-09 16:15 Tx date 2022-02-09 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2022-02-09 16:13 Tx date 2020-09-08 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-24 12:44 Tx date 2021-12-22 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+600,000 vol |
600,000 | |
| Filed 2021-12-24 12:43 Tx date 2020-05-05 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-12-24 12:42 Tx date 2021-12-22 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+400,000 vol |
650,000 | |
| Filed 2021-10-07 17:27 Tx date 2021-10-06 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+200,000 vol |
200,000 | |
| Filed 2021-10-07 17:26 Tx date 2020-09-08 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-07 14:31 Tx date 2021-10-06 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
150,000 | |
| Filed 2021-10-07 14:30 Tx date 2021-07-01 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-07 14:25 Tx date 2021-10-06 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+900,000 vol |
900,000 | |
| Filed 2021-10-07 14:24 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-10-05 15:23 Tx date 2021-10-05 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,357
+11,500 vol $0.205 each |
13,500 | |
| Filed 2021-10-05 15:23 Tx date 2021-10-05 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$420.00
+2,000 vol $0.21 each |
2,000 | |
| Filed 2021-10-05 15:17 Tx date 2021-07-01 |
$HAVN
HAVN Life Sciences Inc. |
Clissold, Gordon Kenneth
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-06-28 12:40 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+50,000 vol |
2,250,000 | |
| Filed 2021-06-28 12:39 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2021-06-28 12:37 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$100,000
+200,000 vol $0.50 each |
1,000,000 | |
| Filed 2021-06-28 12:37 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-200,000 vol |
600,000 | |
| Filed 2020-11-24 17:33 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$400,000
+800,000 vol $0.50 each |
||
| Filed 2020-11-24 17:29 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-800,000 vol |
||
| Filed 2021-05-04 16:26 Tx date 2021-04-29 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,010,000 vol |
1,010,000 | |
| Filed 2021-05-04 16:25 Tx date 2021-04-29 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-1,010,000 vol |
30,000 | |
| Filed 2021-05-04 16:25 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2021-02-09 20:13 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+50,000 vol |
50,000 | |
| Filed 2021-02-09 20:12 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-02 18:32 Tx date 2021-01-15 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
46 - Compensation for services
|
+50,000 vol |
50,000 | |
| Filed 2021-02-02 17:56 Tx date 2020-10-15 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-01 17:08 Tx date 2021-01-15 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2021-02-01 17:05 Tx date 2020-10-15 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-02-01 17:04 Tx date 2020-12-04 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$53,000
+100,000 vol $0.53 each |
100,000 | |
| Filed 2021-02-01 17:02 Tx date 2020-10-15 |
$HAVN
HAVN Life Sciences Inc. |
Staudt, Dennis Joseph
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-27 20:17 Tx date 2021-01-25 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
57 - Exercise of rights
|
-1,000,000 vol |
1,000,000 | |
| Filed 2021-01-27 17:30 Tx date 2021-01-25 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,000,000 vol |
2,600,000 | |
| Filed 2021-01-15 03:42 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Samuelsson, Alexzander
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,000
-100,000 vol $0.80 each |
1,594,987 | |
| Filed 2021-01-15 03:41 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Samuelsson, Alexzander
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-16,810
-20,500 vol $0.82 each |
1,544,987 | |
| Filed 2021-01-15 03:40 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Samuelsson, Alexzander
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-20,335
-24,500 vol $0.83 each |
1,565,487 | |
| Filed 2021-01-15 03:39 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Samuelsson, Alexzander
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-4,200
-5,000 vol $0.84 each |
1,589,987 | |
| Filed 2021-01-14 02:59 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Samuelsson, Alexzander
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,100
-10,000 vol $0.91 each |
1,694,987 | |
| Filed 2021-01-14 02:58 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Samuelsson, Alexzander
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,200
-10,000 vol $0.92 each |
1,704,987 | |
| Filed 2021-01-12 16:52 Tx date 2021-01-07 |
$HAVN
HAVN Life Sciences Inc. |
Casselman, Ivan Jason
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
59 - Exercise for cash
|
$-157,199.20
-196,499 vol $0.80 each |
1,768,488 | |
| Filed 2021-01-06 23:38 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-24,600
-30,000 vol $0.82 each |
1,634,987 | |
| Filed 2021-01-06 23:37 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-25,581
-30,000 vol $0.85 each |
1,664,987 | |
| Filed 2021-01-06 23:37 Tx date 2021-01-05 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-80,000
-100,000 vol $0.80 each |
1,694,987 | |
| Filed 2021-01-06 23:36 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,100
-10,000 vol $0.91 each |
1,794,987 | |
| Filed 2021-01-06 23:35 Tx date 2021-01-04 |
$HAVN
HAVN Life Sciences Inc. |
Chapelle, Susan Laura
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,200
-10,000 vol $0.92 each |
1,804,987 | |
| Filed 2020-12-08 23:07 Tx date 2020-12-04 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$40,000
+80,000 vol $0.50 each |
80,000 | |
| Filed 2020-12-08 23:02 Tx date 2020-09-08 |
$HAVN
HAVN Life Sciences Inc. |
Leong, Gary Joseph
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-11-24 17:33 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$400,000
+800,000 vol $0.50 each |
1,600,000 | |
| Filed 2020-11-24 17:29 Tx date 2020-11-19 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
-800,000 vol |
0 | |
| Filed 2020-10-27 04:31 Tx date 2020-10-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,000,000 vol |
1,250,000 | |
| Filed 2020-10-15 18:35 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Rasode, Barinder Bir
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+200,000 vol |
200,000 | |
| Filed 2020-10-15 18:16 Tx date 2020-09-04 |
$HAVN
HAVN Life Sciences Inc. |
Rasode, Barinder Bir
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-15 16:22 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+1,000,000 vol |
2,000,000 | |
| Filed 2020-10-15 16:21 Tx date 2020-10-11 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+1,000,000 vol |
1,000,000 | |
| Filed 2020-10-15 16:13 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-10-15 13:14 Tx date 2020-10-04 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+750,000 vol |
750,000 | |
| Filed 2020-10-15 13:13 Tx date 2020-10-04 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+1,000,000 vol |
1,040,000 | |
| Filed 2020-10-15 13:12 Tx date 2020-10-04 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Rights RSU
56 - Grant of rights
|
+40,000 vol |
40,000 | |
| Filed 2020-10-15 13:09 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Brar, Ricky
4 - Director of Issuer
Direct Ownership
|
Rights RSU
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 16:25 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Rasode, Barinder Bir
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2020-09-14 16:24 Tx date 2020-09-04 |
$HAVN
HAVN Life Sciences Inc. |
Rasode, Barinder Bir
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 14:03 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2020-09-14 14:02 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Neufeld, Victor
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 13:50 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2020-09-14 13:49 Tx date 2020-05-05 |
$HAVN
HAVN Life Sciences Inc. |
Moore, Tim
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-09-14 13:29 Tx date 2020-09-10 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2020-09-14 13:28 Tx date 2020-06-04 |
$HAVN
HAVN Life Sciences Inc. |
Laidler, Timothy Douglas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|